Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Takeda Pharmaceutical Ltd ADR
(NY:
TAK
)
14.54
-0.11 (-0.75%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Ltd ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Analyzing Takeda Pharmaceutical's Unusual Options Activity
August 03, 2021
Shares of Takeda Pharmaceutical (NYSE:TAK) saw some unusual ...
Via
Benzinga
Know When To Hold 'Em, Know When To Fold 'Em ...
August 02, 2021
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.
Via
Talk Markets
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
August 01, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Understanding Takeda Pharmaceutical's Unusual Options Activity
July 30, 2021
Takeda Pharmaceutical (NYSE:TAK) shares experienced unusual ...
Via
Benzinga
Timeless Values, Life-Changing Progress
June 30, 2021
SOURCE: Takeda
Via
3BL Media
Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
July 30, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
July 29, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Full News Day
July 28, 2021
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.
Via
Talk Markets
Topics
Energy
Exposures
Fossil Fuels
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
July 28, 2021
The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS...
Via
Benzinga
Exposures
Product Safety
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)
July 28, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
XBIO Stock: Xenetic Soars on Private Placement Announcement
July 26, 2021
XBIO stock is continuing a heck of a week. Just days after it was boosted by Takeda's expansion news, it's looking at a big private sale.
Via
InvestorPlace
Containment Plan
July 23, 2021
Today the US decided to cut China risks.
Via
Talk Markets
“Claw-Back” day
July 20, 2021
The rally was just as irrational as the selloff.
Via
Talk Markets
Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
July 20, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal
July 20, 2021
Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight...
Via
Benzinga
Exposures
COVID-19
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine
July 20, 2021
Moderna Inc (NASDAQ: MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) will...
Via
Benzinga
Exposures
COVID-19
Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange
July 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Selloff Round 3
July 13, 2021
Stocks fell across the board in foreign countries, except for Britain which was upbeat.
Via
Talk Markets
New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
July 10, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Recovery Friday
July 09, 2021
The big winners this week were Financials.
Via
Talk Markets
Sell Sell Sell
July 06, 2021
Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday.
Via
Talk Markets
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
July 01, 2021
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...
Via
Benzinga
End Of June
June 30, 2021
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020
June 29, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
June 27, 2021
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big...
Via
Benzinga
Exposures
Product Safety
Summer Friday
June 25, 2021
The stock market tried for another record after yesterday's late blowout over the infrastructure deal.
Via
Talk Markets
Crazy Thursday
June 24, 2021
Today the US stock market went ballistic probably because of a higher joblessness level than expected.
Via
Talk Markets
Wednesday Is A Normal Day
June 23, 2021
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises.
Via
Talk Markets
The First Day Of Summer And Prime Day
June 21, 2021
The bull is back in business today.
Via
Talk Markets
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.